BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 183875)

  • 1. [Renal production and excretion of AMPc after intravenous infusion of salmon calcitonin in man].
    Kuhn JM; Cazor JL; Isaac R; Nivez MP; Ardaillou R; Fillastre JP
    C R Seances Soc Biol Fil; 1976; 170(2):449-55. PubMed ID: 183875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salmon calcitonin on renal excretion of adenosine 3', 5' monophosphate in man.
    Ardaillou R; Isaac R; Nivez MP; Kuhn JM; Cazor JL; Fillastre JP
    Horm Metab Res; 1976 Mar; 8(2):136-40. PubMed ID: 177347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transient increase in renal clearance of phosphate in response to continuous infusion of salmon calcitonin in rats.
    Koide Y; Kugai N; Yamashita K; Shimazawa E; Ogata E
    Endocrinol Jpn; 1977 Aug; 23(4):295-304. PubMed ID: 923518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal effects of salmon calcitonin in man.
    Paillard F; Ardaillou R; Malendin H; Fillastre JP; Prier S
    J Lab Clin Med; 1972 Aug; 80(2):200-16. PubMed ID: 5044777
    [No Abstract]   [Full Text] [Related]  

  • 6. A transient increase in renal clearance of phosphate in response to continuous infusion of salmon calcitonin in rats.
    Koide Y; Kugai N; Yamashita K; Shimazawa E; Ogata E
    Endocrinol Jpn; 1976 Aug; 23(4):295-304. PubMed ID: 1024037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma immunoreactive N-terminal parathyroid hormone and cyclic AMP and cyclic GMP urinary levels in man after I. M. administration of two different doses of porcine calcitonin.
    Vigo PL; Milhaud G; Peracchi M; Girardello R; Ortolani S; Polli EE
    Biomedicine; 1980 Dec; 33(8):255-9. PubMed ID: 6260260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man.
    Caniggia A; Gennari C; Vattimo A; Nardi P; Nuti R; Galli M
    Calcif Tissue Res; 1976 Apr; (2):209-15. PubMed ID: 177154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.
    Kaminsky NI; Broadus AE; Hardman JG; Jones DJ; Ball JH; Sutherland EW; Liddle GW
    J Clin Invest; 1970 Dec; 49(12):2387-95. PubMed ID: 5480862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of carbocalcitonin and salmon calcitonin, after endonasal administration in man.
    Cecchettin M; Segre G
    Biomed Pharmacother; 1995; 49(4):215-8. PubMed ID: 7669941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion.
    Martino JA; Earley LE
    J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR; Casper AG
    J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man.
    DeFronzo RA; Cooke CR; Andres R; Faloona GR; Davis PJ
    J Clin Invest; 1975 Apr; 55(4):845-55. PubMed ID: 1120786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the renal tubular interactions of thyrocalcitonin, cyclic adenosine 3',5'-monophosphate, 25-hydroxycholecalciferol, and calcium ion.
    Puschett JB; Beck WS; Jelonek A; Fernandez PC
    J Clin Invest; 1974 Mar; 53(3):756-67. PubMed ID: 4359939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Source of urinary cyclic AMP in response to calcitonin and parathyroid hormone in the rat.
    Firek AF; Ramanathan S; Suh SM
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):147-50. PubMed ID: 2158136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dibutyryl cyclic adenosine 3',5'-monophosphate, theophylline, and other nucleotides upon calcium and phosphate metabolism.
    Rasmussen H; Pechet M; Fast D
    J Clin Invest; 1968 Aug; 47(8):1843-50. PubMed ID: 4299012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of urinary concentration in nephrogenic diabetes insipidus.
    McConnell RF; Lorentz WB; Berger M; Smith EH; Carvajal HF; Travis LB
    Pediatr Res; 1977 Jan; 11(1 Pt 1):33-6. PubMed ID: 188007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced parathyroid hormone response to peroral phosphate in osteoporotic patients.
    Ittner J; Dambacher MA; Muff R; Rüegsegger P; Trechsel U; Fischer JA
    Miner Electrolyte Metab; 1986; 12(3):199-203. PubMed ID: 3014300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natriuretic effect of calcitonin in man.
    Bijvoet OL; van der Sluys Veer J; de Vries HR; van Koppen AT
    N Engl J Med; 1971 Apr; 284(13):681-8. PubMed ID: 4322953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.